Showing results (111-120 of 217) with videos related to

Sort By:
Pageof 22
Investigational New Drugs|July 6, 2011
Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancerKen Kato, Keisho Chin, Takaki Yoshikawa, et al.
Japanese Journal of Clinical Oncology|July 10, 2019
Efficacy and safety of pemetrexed plus cisplatin as first-line chemotherapy in advanced malignant peritoneal mesotheliomaYusuke Nagata, Ryoichi Sawada, Atsuo Takashima, et al.
Breast Cancer Research and Treatment|March 6, 2004
Terminal endbuds and acini as the respective major targets for chemical and sporadic carcinogenesis in the mammary glands of human c-Ha-ras protooncogene transgenic ratsTetsuya Hamaguchi, Yoichiro Matsuoka, Hiroaki Kawaguchi, et al.
Scientific Reports|July 15, 2025
Developing a machine-learning model to enable treatment selection for neoadjuvant chemotherapy for esophageal cancerYutaka Miyawaki, Masataka Hirasaki, Yasuo Kamakura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2010
Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumorsTetsuya Hamaguchi, Toshihiko Doi, Takako Eguchi-Nakajima, et al.
Japanese Journal of Clinical Oncology|February 15, 2014
Panitumumab in Japanese patients with unresectable colorectal cancer: a post-marketing surveillance study of 3085 patientsNarikazu Boku, Kenichi Sugihara, Yuko Kitagawa, et al.
Cancer Science|December 11, 2008
Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancerYoshinori Hirashima, Yasuhide Yamada, Junichi Matsubara, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 18, 2011
Neuroendocrine tumors of the stomach: chemotherapy with cisplatin plus irinotecan is effective for gastric poorly-differentiated neuroendocrine carcinomaNatsuko Tsuda Okita, Ken Kato, Daisuke Takahari, et al.
Japanese Journal of Clinical Oncology|December 3, 2019
Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial)Kenichi Miyamoto, Atsuo Takashima, Junki Mizusawa, et al.
Asia-Pacific Journal of Clinical Oncology|August 7, 2015
Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patientsTetsuji Terazawa, Hitoshi Nishitani, Ken Kato, et al.
Pageof 22